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A R T I C L E  I N F O   






Adverse outcome pathway 
A B S T R A C T   
Human biomonitoring (HBM) studies have demonstrated widespread and daily exposure to bisphenol A (BPA). 
Moreover, BPA structural analogues (e.g. BPS, BPF, BPAF), used as BPA replacements, are being increasingly 
detected in human biological matrices. BPA and some of its analogues are classified as endocrine disruptors 
suspected of contributing to adverse health outcomes such as altered reproduction and neurodevelopment, 
obesity, and metabolic disorders among other developmental and chronic impairments. One of the aims of the 
H2020 European Human Biomonitoring Initiative (HBM4EU) is the implementation of effect biomarkers at large 
scales in future HBM studies in a systematic and standardized way, in order to complement exposure data with 
mechanistically-based biomarkers of early adverse effects. This review aimed to identify and prioritize existing 
biomarkers of effect for BPA, as well as to provide relevant mechanistic and adverse outcome pathway (AOP) 
information in order to cover knowledge gaps and better interpret effect biomarker data. A comprehensive 
literature search was performed in PubMed to identify all the epidemiologic studies published in the last 10 years 
addressing the potential relationship between bisphenols exposure and alterations in biological parameters. A 
total of 5716 references were screened, out of which, 119 full-text articles were analyzed and tabulated in detail. 
This work provides first an overview of all epigenetics, gene transcription, oxidative stress, reproductive, glu-
cocorticoid and thyroid hormones, metabolic and allergy/immune biomarkers previously studied. Then, pro-
mising effect biomarkers related to altered neurodevelopmental and reproductive outcomes including brain- 
derived neurotrophic factor (BDNF), kisspeptin (KiSS), and gene expression of nuclear receptors are prioritized, 
providing mechanistic insights based on in vitro, animal studies and AOP information. Finally, the potential of 
omics technologies for biomarker discovery and its implications for risk assessment are discussed. To the best of 
our knowledge, this is the first effort to comprehensively identify bisphenol-related biomarkers of effect for HBM 
purposes.   
1. Introduction 
Bisphenol A (BPA) is a synthetic high production monomer used in 
polycarbonate plastics and epoxy resins in a wide range of consumer 
products. These include for instance canned food and beverages, plastic 
bottles, food containers, toys, thermal receipts, and medical equipment 
among many other applications (Calafat et al., 2009; Cao et al., 2009; 
Carwile et al., 2009; Ehrlich et al., 2014; Fleisch et al., 2010; Iribarne- 
Durán et al., 2019; Molina-Molina et al., 2019; Vandenberg et al., 
2007). More recently, BPA has even been detected in infants’ socks, 
highlighting the novel role of textiles as potential source of bisphenol 
exposure (Freire et al., 2019). Although diet is one of the predominant 
sources of BPA exposure in the general population due to the leaching 
of BPA from packaging materials and can liners into food and beverages 
(Buckley et al., 2019; Vandenberg et al., 2010), other sources and 
routes also contribute to human exposure (Freire et al., 2019; Molina- 
Molina et al., 2019; Morgan et al., 2018). Indeed, non-dietary sources 
(e.g. dermal and inhalation) have been proposed to be of equal or even 
higher toxicological relevance than dietary sources based on markedly 
different toxicokinetics (Liu and Martin, 2017; von Goetz et al., 2017). 
Assessing human exposure to BPA is challenging, mainly due to its 
short biological half-life and rapid excretion. Furthermore, problems 
related to external contamination during sampling and/or analytical 
processes have been reported in some studies (Teeguarden et al., 2016; 
Ye et al., 2013). Biomonitoring studies have assessed BPA in blood 
plasma, serum and tissues; however, the analysis of total urinary BPA 
(i.e. free BPA and phase II conjugates) after enzymatic deconjugation is 
widely recognized as the standard approach (Calafat et al., 2015). Thus, 
HBM studies have demonstrated widespread and daily exposure to BPA, 
detecting urinary BPA in more than 90% of the general European and 
US populations at low concentrations (Becker et al., 2009; Calafat et al., 
2008). The advantages of urine as exposure matrix include its non-in-
vasiveness and the possibility to collect repeated samples over time, 
which is important for a reliable assessment of non-persistent chemicals 
with short biological half-lives and episodic exposure patterns (Vernet 
et al., 2019). However, urinary BPA concentrations do not directly in-
form about bioactive concentrations in specific tissues or internal le-
vels, nor differentiate among exposure routes. Hence, some studies have 
suggested that measurements in other biological matrices would also be 
convenient under specific circumstances (Stahlhut et al., 2016). Ad-
ditionally, recent data requiring further confirmation suggests that BPA 
exposure assessment using indirect analytical techniques involving 
enzymatic deconjugation could underestimate human urinary BPA 
concentrations depending on the protocol used (Gerona et al., 2019). 
These inherent limitations related to BPA exposure assessment in HBM 
studies must be considered when interpreting exposure-health asso-
ciations. 
BPA is a known endocrine disrupting chemical (EDC) that can in-
terfere with hormonal balance even at low doses (Rubin, 2011). Its 
mechanisms of action are particularly complex since BPA can bind not 
only to nuclear and membrane estrogen receptors but also to thyroid, 
glucocorticoid, and peroxisome proliferator-activated receptors. It can 
also interact with steroidogenic enzymes, among other molecular tar-
gets (Acconcia et al., 2015; Mustieles et al., 2018a; Rubin, 2011; 
Wetherill et al., 2007). Additionally, BPA has been shown to exert 
epigenetic modifications (e.g. altered DNA methylation) that could 
partially explain BPA effects on various health endpoints (Ferreira 
et al., 2015; Kundakovic and Champagne, 2011). Taken together, this 
biological promiscuity might explain the pleiotropic effects exerted by 
BPA on behavior, reproduction, and metabolism in both experimental 
animals (Nesan et al., 2018; Peretz et al., 2014; Wassenaar et al., 2017) 
and human populations (Chevalier and Fénichel, 2015; Mustieles et al., 
2015; Peretz et al., 2014). Other health outcomes suspected of being 
affected by BPA exposure include hormone-dependent cancers, the 
immune system and developmental diseases (Bansal et al., 2018; 
Murata and Kang, 2018; Rochester, 2013). Although associations found 
in human populations cannot demonstrate causality, BPA effects on 
different systems and organs are supported by an extensive body of 
experimental evidence. For some endpoints such as reproduction and 
behavior, the epidemiological findings are also increasingly consistent 
(Mustieles et al., 2018a, 2015; Peretz et al., 2014). 
BPA has recently been classified as a reproductive toxicant and a 
substance of very high concern by the European Chemicals Agency 
(ECHA, 2016, 2017). However, most BPA replacements are structural 
analogs such as bisphenol S (BPS) and bisphenol F (BPF), which also 
show hormonal activity (Molina-Molina et al., 2013; Rochester and 
Bolden, 2015) and are increasingly detected in human urine (Yang 
et al., 2014b; Ye et al., 2015). Many other bisphenol analogues, in-
cluding bisphenol AF (BPAF), bisphenol AP (BPAP), bisphenol Z (BPZ), 
and bisphenol B (BPB) have also been shown to exert estrogenic ac-
tivities (Chen et al., 2016; Mesnage et al., 2017; Moreman et al., 2017), 
with the exception of tetramethyl bisphenol F (Soto et al., 2017). Since 
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recent animal studies have shown that exposure to bisphenol analogues 
such as BPS, BPF and BPAF induce a similar pattern of neurobehavioral 
disruption as BPA (Rosenfeld, 2017), there is an urgent need for new 
monitoring approaches that can timely address the potential risks posed 
by bisphenol analogues in order to avoid regrettable substitutions of 
BPA and other environmental chemicals. 
The European Human Biomonitoring Initiative (HBM4EU) re-
presents a joint effort of 28 countries and the European Commission, co- 
funded by Horizon 2020. Its main aim is to coordinate and advance 
HBM in Europe in a standardized way to provide evidence for policy- 
making. The HBM4EU consortium identified several critical questions 
concerning bisphenols, which include the identification of bisphenol- 
related effect biomarkers and their mechanistic pathways following the 
adverse outcome pathway (AOP) framework. Effect biomarkers are 
measurable biological changes helpful for establishing dose–response 
and mechanistic relationships. By providing a link between exposure, 
internal dose and early health impairment, they could be extremely 
useful in order to improve HBM and risk assessment of chemicals with a 
very short half-life (Decaprio, 1997) (Fig. 1). Based on the WHO and the 
Committee on Human Biomonitoring for Environmental Toxicants 
(IPCS-WHO, 1993; NRC, 2006), effect biomarkers are defined as “a 
measurable biochemical, physiologic, behavioral, or other alteration in 
an organism that, depending on the magnitude, can be recognized as 
associated with an established or possible health impairment.” 
Fig. 1 presents a simplified unidirectional conceptualization of the 
exposure-disease continuum for practical purposes. However, it is 
worth noting that real-life scenarios are much more complex and dy-
namic. The development of an adverse effect in humans will depend on 
the route of exposure to BPA and the internal dose at the target organ, 
the critical window of exposure, individual susceptibility, as well as 
potential non-monotonic dose-responses together with adaptive me-
chanisms and feedback regulations (Mustieles and Arrebola, 2020). An 
important characteristic that complicates the evaluation of BPA effects 
in both experimental toxicology and human settings is the probable 
existence of non-monotonic dose–response relationships, also typical of 
endogenous hormones (Hill et al., 2018; Vandenberg et al., 2019, 
2012). In relation to biomarkers of effect, different biomarker profiles 
could be expected for those exposed to the highest levels compared to 
other exposure ranges, as well as for occupationally-exposed subjects 
compared to the general population. Thus, the shape of exposure-health 
associations should be evaluated a priori, without assuming the 
existence of linearity across all exposure ranges. 
Based on the needs identified, this work aimed to: i) conduct a 
comprehensive review of the literature to create an inventory of ex-
isting effect biomarkers used in epidemiologic studies related to bi-
sphenols exposure and specific health endpoints of concern; ii) prior-
itize the most relevant biomarkers of effect for HBM purposes; iii) 
provide relevant mechanistic and/or AOP information to improve the 
interpretation of biomarker data; and iv) identify gaps in knowledge 
and potential novel effect biomarkers to be investigated in future bio-
monitoring programs. To the best of our knowledge, this is the first 
effort to identify the best epidemiological effect biomarkers for BPA and 
its analogues for HBM purposes. 
2. Methods 
2.1. Literature search methodology 
This comprehensive review covered all scientific publications 
available in the PubMed/MEDLINE database from January 2008 up to 
January 2018 with the aim of identifying effect biomarkers linked to 
bisphenol exposure and human adverse health effects. To decomplexify 
the very large amount of references found and prioritize the most re-
levant effect biomarkers, three general steps were followed: 
First, relevant search terms including both MeSH and non-MeSH 
terms (Suppl. Table 1) for both the exposure (bisphenols) and selected 
health endpoints were selected. To cover as much information as pos-
sible, the term “bisphenol’’ was chosen as the key search term for ex-
posure. Six health endpoints were a priori chosen according to their 
relevance for BPA-related human health and HBM4EU objectives: i) 
neurodevelopment, ii) reproductive diseases, iii) endocrine diseases, iv) 
obesity, cardiovascular and metabolic disorders, v) allergies and im-
munological diseases and vi) cancer. Afterwards, boolean operators 
‘AND’ and ‘OR’ were used to combine search terms (Suppl. Table 1). 
Several PubMed filters were employed to gain precision: a) “Full-text” 
articles and b) published in the last “10 years”. As a result of this ex-
ploratory search, 5716 potential references were found (Suppl. Fig. 1). 
A screening procedure of the abovementioned 5716 abstracts was 
performed to identify relevant articles reporting effect biomarker in-
formation for each outcome of interest. At least two researchers parti-
cipated in the selection of abstracts for each health endpoint. The fol-
lowing exclusion criteria were applied: a) articles with only exposure 
Fig. 1. Conceptual pathway representing the continuum between environmental chemical exposure and clinical disease (adaptation of the National Research Council 
biomarker paradigm identifying concrete stages in the exposure-disease continuum). Exposure biomarkers measure the actual absorbed dose (“internal dose”) and 
active dose at the putative target organ/tissue (“biologically effective dose”). Effect biomarkers measure early molecular or biochemical/cellular responses in target 
or non-target tissues (“early biological effect”), functional or structural changes in affected cells or tissues (“altered structure/function”), or actual clinical disease. 
Susceptibility biomarkers help to identify individuals with genetically mediated predisposition to xenobiotic-induced toxicity (Adapted from De Caprio, 1997). 
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data, b) non-original research articles, and c) articles with only ex-
perimental or in vivo studies. Then, duplicate references were removed.  
Suppl. Fig. 2 shows the flow-chart of the selection process. 
Finally, all the information provided by each of the 119 selected 
studies was collected, analyzed, synthetized and tabulated (Suppl. 
Tables 2-9). We reported study quality parameters such as study design; 
characteristics of the population including sample size; exposure as-
sessment (biological matrix, number of samples analyzed, methods 
followed and quality measures); the effect biomarkers measured in each 
biological matrix, and the analytical method used; as well as the main 
results and conclusions. Throughout this in-depth screening, we ad-
ditionally considered criteria such as the feasibility of the biomarker 
together with its specificity, sensitivity, and reliability, and if a poten-
tial mode of action (MoA) and/or adverse outcome pathway (AOP) 
were previously described. 
After conducting the review and analyzing its results, some gaps in 
knowledge were identified. Therefore, a fourth post-hoc step was per-
formed by hand-search to gather AOP information (https://aopwiki. 
org/) and specific BPA mechanistic studies (PubMed database) that may 
experimentally support the implementation of selected promising novel 
effect biomarkers found in this work [brain-derived neurotrophic factor 
(BDNF), kisspeptin (KiSS) and gene expression of nuclear receptors]. 
2.2. Classification of effect biomarkers in the AOP context 
After analyzing all references, effect biomarkers were classified into 
two main categories based on their level of biological organization: 
molecular effect biomarkers and cellular/biochemical effect bio-
markers. This classification was based mainly on the AOP framework. 
AOPs have been developed recently and are conceptual constructs that 
integrate existing knowledge on the linkage between a direct molecular 
initiating event (MIE), through its associated key events (KEs) until the 
development of an adverse outcome (AO) at a biological level of or-
ganization relevant to risk assessment (Ankley et al., 2010) (see Fig. 2). 
Within this classification, molecular effect biomarkers include biolo-
gical markers such as epigenetic modifications (e.g., DNA methylation) 
and changes in gene expression. These molecular effect biomarkers are 
more likely to coincide with early KEs or even molecular initiating 
events (MIEs) in the AOP framework, meaning that these biomarkers 
are potentially closer to the exposure. The main limitation is that their 
predictive potential for adverse effects is most of the time unknown, in 
particular for epigenetic biomarkers. In contrast, biochemical or cel-
lular biomarkers (e.g., hormones, insulin and glucose levels, etc.) are 
generally closer to the phenotype and are therefore more likely to be 
representative of late KEs in the AOP framework. The main strength of 
biochemical/cellular biomarkers is their predictive potential for dis-
ease; however, they may be less specific. Overall, the combination of 
both molecular and biochemical effect biomarkers, when substantiated 
by an AOP-like conceptualization of the in vitro and in vivo evidence, 
appears as an optimal approach for improving the causal understanding 
of exposure-disease relationships in HBM studies. 
3. Results and discussion 
3.1. Inventory and description of existing effect biomarkers identified in 
human studies 
3.1.1. Molecular effect biomarkers 
Molecular effect biomarkers identified in this literature search in-
clude epigenetic and gene expression biomarkers (Suppl. Table 2) as 
well as oxidative stress markers (Suppl. Table 3), which are summarized 
in Table 1. 
3.1.1.1. Epigenetic biomarkers. Epigenetics refers to heritable 
alterations in gene expression that do not involve alterations in the 
DNA sequence. The main epigenetic regulators include DNA 
methylation, histone modifications, and microRNAs. Overall, 
epigenetic markers are stable biomarkers that can be transmitted to 
subsequent generations and studies have already shown that 
modifications of DNA methylation patterns can potentially serve as 
relevant effect biomarkers for a wide range of environmental 
contaminants such as dioxins, plasticizers, pesticides, and 
hydrocarbons (Manikkam et al., 2012). 
A variety of epigenetic markers associated with exposure to bi-
sphenols have been inventoried through this literature search. These 
epigenetic markers were related to different health outcomes such as 
reproduction, neurodevelopment, obesity and metabolic disorders. 
Among the retrieved papers, eight studies analyzed hypo- or hyper- 
methylation of specific candidate genes, one study focused on DNA 
hydroxymethylation, and two studies investigated microRNA altera-
tions (Suppl. Table 2). 
Regarding hypo- or hyper DNA methylation markers, associations 
between urinary BPA concentrations and alterations in the methylation 
patterns of DNA isolated from saliva of genes involved in immune 
function, transport activity, metabolism, and caspase activity were 
observed in pre-pubescent girls from Egyptian rural (n = 30) and urban 
Fig. 2. Visualization of the AOP network 
and the analogy between intermediate steps 
and effect biomarkers (EBM) of interest for 
HBM. Both early KEs (i.e., early biological 
changes such as epigenetic modifications 
and altered gene expression) and late KEs 
(i.e., altered structure or function markers 
such as sexual hormones and glucose/in-
sulin) in a given AOP have the potential to 
be assessed or implemented as EBM in epi-
demiologic studies. 
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areas (n = 30) using untargeted genome-wide profiling (Kim et al., 
2013). More specifically, homeobox A10 (HOXA10) involved in embryo 
morphogenesis; breast cancer 1 (BRCA1), involved in DNA transcrip-
tion and repair; and brain expressed X-linked 2 (BEX2) associated with 
estrogens and cell cycle, were found to be hypo-methylated. Another 
study reported alterations in DNA methylation in relation to BPA ex-
posure assessed in fetal liver tissue and signal transducer and activator 
of transcription 3 (STAT3) also evaluated in fetal liver samples (n = 50) 
(Weinhouse et al., 2015). STAT3 signaling is associated with in-
flammatory liver cancer (Svinka et al., 2014) and STAT3 methylation 
has been proposed as a possible biomarker for liver tumor risk 
(Weinhouse et al., 2015). Increased site-specific methylation of COMT, 
a gene that encodes for catechol-O-methyltransferase involved in the 
metabolism of catecholamines and SULT2A1, a phase II metabolism 
enzyme, was also observed in human fetal liver in response to higher 
BPA concentrations (Nahar et al., 2014). Hanna et al. (2012) reported 
an inverse correlation between serum BPA concentrations and altered 
testis-specific protein 50 (TSP50) gene methylation levels in the blood 
of women (n = 35) who were undergoing in vitro fertilization. Although 
the exact function of TSP50 is not fully elucidated, an increased ex-
pression of TSP50 due to loss of its normal methylation was observed in 
breast cancer epithelial cells, but not in normal breast tissues (Shan 
et al., 2002). 
A recent study using data from the Columbia Center for Children’s 
Environmental Health (CCCEH) cohort showed that higher prenatal 
urinary BPA concentrations during the third trimester of gestation were 
prospectively associated with altered cord blood DNA methylation of 
BDNF Exon IV at two CpG sites in a sex-specific manner (n = 41 fe-
males, n = 40 males), and these effects were more pronounced in boys 
compared to girls (Kundakovic et al., 2015). Importantly, prenatal BPA 
was previously associated with behavior problems in 198 children from 
this same cohort (Perera et al., 2012). This study was considered of high 
quality based on its prospective design, robust exposure and effect 
measurements, and the validation of its results using a rodent model 
investigating BDNF DNA methylation in both brain tissue and whole 
blood in response to BPA dosing (Kundakovic et al., 2015). BDNF is a 
member of the neurotrophin family and is a key regulator of neuronal 
synaptic plasticity. BDNF is considered a biomarker specific for neu-
robehavioral disorders as it is involved in the pathogenesis of various 
psychiatric ailments such as depression, anxiety, schizophrenia and 
bipolar disorder (Autry and Monteggia, 2012). For instance, altered 
BDNF levels have been associated with attention deficit, cognitive skill 
decline and behavioural defects in children (Cubero-Millán et al., 2017; 
Yeom et al., 2016). From a neurodevelopmental point of view, DNA 
methylation of BDNF Exon IV constitutes one of the most promising 
biomarkers identified for BPA. 
In another study following a targeted analysis, long interspersed 
nuclear elements (LINE) were reported to be hypo-methylated in the 
spermatozoa of Chinese factory workers exposed to BPA (n = 77) 
compared to non-exposed workers (n = 72) (Miao et al., 2014). LINEs 
are a group of non-long terminal repeat retrotransposons that comprises 
approximately 17% of the human genome and are normally heavily 
methylated in order to prevent genome instability. It is also considered 
to be a surrogate marker of global DNA methylation. Experimental 
studies conducted on human fetal liver samples (n = 18) found an 
association between BPA concentrations in liver and hypomethylation 
of LINEs, long terminal repeat (LTRs), satellite repeats and DNA ele-
ments (Faulk et al., 2016). Moreover, an association between BPA 
concentrations and global DNA methylation was observed in placenta 
samples by using targeted LINE-1 assay (Nahar et al., 2015). 
DNA hydroxylmethylation is another epigenetic biomarker related 
to high BPA exposure. In this epigenetic modification, the C5 cytosine 
of the DNA is replaced with a hydroxymethyl group to form 5-hydro-
xymethylcytosine (5-hmc), which is considered an intermediate step in 
the DNA demethylation process (Richa and Sinha, 2014). Zheng et al. 
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using sperm samples of men who were occupationally exposed to BPA. 
Compared to controls without occupational BPA exposure, the total 
levels of 5hmc increased significantly (19.37%) in BPA occupationally- 
exposed men (Zheng et al., 2017). A global increase in DNA hydro-
xymethylation profile (72.6% of the genome) in LINE-1 repeats, im-
printed genes and other important genes involved in DNA damage re-
sponse was observed in BPA-exposed workers compared to non-exposed 
workers (60% of the genome). However, it is worth noting that this 
study included a relatively small sample size (30 BPA-exposed men and 
26 controls) with very high urinary BPA concentrations in exposed 
workers (Zheng et al., 2017). 
MicroRNAs (miRNAs) constitute another important epigenetic bio-
marker associated with BPA exposure. miRNAs are approximately 22 
nucleotide long non-coding RNAs capable of regulating gene expres-
sion. Changes in the miRNA expression patterns have been observed 
under several disease conditions (Tüfekci et al., 2014), and also fol-
lowing exposure to environmental contaminants (Sollome et al., 2016). 
An epidemiological study performed in Italy (n = 40) observed asso-
ciations between BPA concentrations in the placentas of patients un-
dergoing therapeutic abortion and upregulation of 34 miRNAs and their 
target genes (De Felice et al., 2015). More specifically, a strong corre-
lation was found between mir-146a upregulation and BPA concentra-
tions both measured in placental tissue. In contrast, the National Chil-
dren’s Study (NCS) Vanguard Cohort, which involved a larger sample 
size (n = 110), found no association between altered miRNA levels and 
BPA concentrations in the placentas (Li et al., 2015). These conflicting 
results highlight the difficulty to interpret and identify relevant effect 
biomarkers specific to bisphenols exposure in human populations 
where exposure is complex (i.e., multiplicity of exposures, exposure 
misclassification issues) and biological markers not totally specific to 
chemical families. 
The literature search has identified a wide range of epigenetic bio-
markers associated with BPA exposure for different health outcomes 
and different biological matrices (including invasive ones such as liver 
samples from aborted fetuses). Notwithstanding, a prioritization is 
needed to ensure that some of these biomarkers can be progressively 
implemented in HBM studies. 
3.1.1.2. Gene expression biomarkers. Gene expression profiling of 
mRNA transcripts in any cell type at a given time is a relevant 
approach to study cellular function at a global level, as well as 
genotype-phenotype interactions. Thus, variations in gene expression 
could potentially be used as relevant biomarkers of what is occurring in 
a given tissue, with implications for the prediction of health outcomes 
and elucidation of potential mechanisms (Suppl. Table 2). As a 
limitation, it is often unclear to which extent the assessment of gene 
expression in non-invasive matrices such as blood represents gene 
expression in a given target tissue. 
Nuclear hormone receptors (NRs) constitute transcription factors 
that are critical for sensing the hormonal signals that regulate a wide 
range of physiological processes from metabolism to development 
(Sever and Glass, 2013). A study from Italy involving 100 male subjects 
reported a positive association between urinary BPA concentrations and 
increased expression of two estrogen-responsive genes in peripheral 
blood leukocytes, i.e., the estrogen receptor beta (ERβ) and the es-
trogen-related receptor alpha (ERRα) (Melzer et al., 2011). This study 
did not involve women subjects in order to avoid the bias that could 
possibly occur due to cyclic hormonal variations in premenopausal 
women. Another Italian study analyzed changes in the expression of 
hormone receptors in peripheral blood mononuclear cells of both fertile 
and infertile men from three different areas (metropolitan, urban and 
rural areas) (La Rocca et al., 2015). Higher concentrations of serum 
total BPA concentrations in infertile men were positively correlated 
with increased expression of nuclear receptors: ERα, ERβ, AR, AhR and 
PXR. 
Another candidate gene associated with BPA exposure is kisspeptin 
(KiSS). Kisspeptins are neuroactive (hypothalamic) peptides, encoded 
by the KISS1 gene, that stimulate gonadotropin releasing hormone 
(GnRH) and play an essential role in the onset of puberty and main-
tenance of normal reproductive functions (Clarke et al., 2015). A study 
conducted on 262 mother–child pairs from China (192 pairs from an e- 
waste recycling town and 70 from a control area) showed that KISS1 
and leptin mRNA expression levels in placental tissue were higher in the 
e-waste than in the control group (Xu et al., 2015). Moreover, cord 
blood free (unconjugated) BPA concentrations were positively asso-
ciated with an increased expression of both markers (Xu et al., 2015). 
Due to the important role of kisspeptins in regulating puberty, they 
could be important effect biomarkers for assessing BPA-associated in-
duction of precocious puberty in adolescents. 
3.1.1.3. Oxidative stress and inflammatory biomarkers. Damage from 
endogenously produced oxygen radicals occurs to lipids in cellular 
membranes, proteins and nucleic acids (Halliwell and Gutteridge, 
2015). Several oxidative stress biomarkers, e.g. 8-oxo-7,8-dihydro-2′- 
deoxyguanosine (8-OHdG or 8-oxodGuo), malondialdehyde (MDA) and 
8-iso-prostaglandin F2α (8-isoprostane), have been studied for decades 
and are included in several AOPs (e.g. 8-OHdG in AOP 17 and MDA in 
AOP 260) (Hofer, 2001). However, their use in environmental 
epidemiological studies investigating health effects related to non- 
persistent chemical’s exposure is recent. 
Several oxidative stress biomarkers were identified in 14 epide-
miological studies assessing bisphenols (Suppl. Table 3). Overall, the 
studies indicated that exposure to BPA mainly assessed in urine was 
positively associated with increased urinary levels of 8-OHdG, MDA 
and/or 8-isoprostane to some extent (Asimakopoulos et al., 2016; Kim 
and Hong, 2017; Lv et al., 2016; Watkins et al., 2015; Yang et al., 
2014a; Yang et al., 2009; Yi et al., 2011; Zhang et al., 2016). On the 
contrary, a few studies found no associations (Erden et al., 2014b; Hong 
et al., 2009), while results were inconsistent in others (for instance,  
Huang et al. (2017) found a positive association with 8-isoprostane, but 
not with 8-OHdG). No studies reported negative associations for any of 
the oxidative stress biomarkers evaluated and BPA exposure. Two stu-
dies reported positive associations between exposure to the structural 
analogue BPS and higher urinary 8-OHdG levels (Asimakopoulos et al., 
2016; Zhang et al., 2016). There are methodological issues of concern 
related to artefactual MDA formation and lack of HPLC separation in 
some studies (Grotto et al., 2009), and therefore 8-OHdG and 8-iso-
prostane excreted and measured in urine appear as the most suitable 
markers of oxidative stress related to bisphenols exposure. 
The mechanisms by which BPA induces oxidative stress are not 
completely elucidated (Gassman, 2017). The main metabolic pathway 
for bisphenols is by conjugation leading to glucuronide or sulfate con-
jugates that are mainly excreted in urine. A minor metabolic pathway 
described is cytochrome P-450-mediated hydroxylation to a catechol, 
followed by further transformation to an o-quinone (Kovacic, 2010), 
being the latter capable of redox cycling with generation of ROS 
(Kovacic, 2010; Sakuma et al., 2010). 
Other oxidative stress markers measured included o,o’-di-tyrosine 
(formed from oxidation of two nearby tyrosines within proteins that 
underwent hydrolysis); 3-chloro-tyrosine (from neutrophil myeloper-
oxidase release of hypochlorous acid (HOCl) reacting with tyrosine); 
markers of nitrosative stress (e.g. 8-nitro-guanine and 3-nitro-tyrosine) 
formed from reaction with the oxidants peroxynitrite anion (ONOO–) or 
nitrogen dioxide (NO2), but also total thiols and GSH levels (sulfhydryl 
-SH groups are susceptible to oxidative damage, which can lower the 
SH concentration). Additionally, assessment of protein carbonyls (ad-
ducts to protein formed from metal-catalyzed oxidation of amino acids 
or from aldehyde including lipid peroxidation reactions) and activities 
or genetic polymorphisms (e.g. antioxidant enzymes such as catalase 
and glutathione peroxidase) were also reported. Although less studied 
in relation to bisphenols, urinary HNE-MA (4-hydroxy-2-nonenal-mer-
capturic acid) has potential for becoming a reliable biomarker of lipid 
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peroxidation, which was recently associated with both higher urinary 
BPA and BPF concentrations (Wang et al., 2019). 
Oxidative stress biomarkers comprehensively capture disruptions at 
various levels of biological organization. As a limitation, these bio-
markers are not specific for a given exposure such as BPA, or for a 
unique organ or system, and can also originate from external sources 
such as food. 
3.1.2. Biochemical effect biomarkers 
Biochemical effect biomarkers identified in the literature search are 
summarized in Table 2. 
3.1.2.1. Reproductive hormones (RHs). RHs coordinate a myriad of 
physiological functions. The most important ones include their role in 
sexual differentiation of both gonads and brain during development, 
but also on metabolic organs (Bao and Swaab, 2011). Additionally, RHs 
maintain these functions during adulthood. In total, 32 studies 
reporting biomarker data on reproductive hormones were retrieved 
from the literature search and organized based on similar windows of 
development and/or study designs (Suppl. Table 4). The most relevant 
articles are discussed below. 
Few studies explored associations between prenatal BPA exposure 
and maternal or offspring sex hormone levels. Prenatal urinary BPA 
concentrations were associated with decreased total testosterone (TT) 
cord blood levels and testosterone:17β-estradiol (T/E2) ratio among 
male neonates (Liu et al., 2016); whereas cord blood BPA concentra-
tions were associated with lower cord blood insulin-like peptide 3 
(INSL3) levels but not with TT in a case-control study of cryptorchidism 
(Chevalier et al., 2015). INSL3 is a major regulator of testicular descent, 
and a marker of Leydig cells maturation. Since INSL3 is not acutely 
regulated by the hypothalamus-pituitary (HP) axis, but is constitutively 
secreted by Leydig cells, it is considered a valid marker for their number 
and status (Sansone et al., 2019) that could be further implemented in 
environmental epidemiologic studies, together with anti-Müllerian 
hormone (AMH), an analogous marker of Sertoli cells maturation 
(Sansone et al., 2019). 
Peripuberty and adolescence represent understudied critical periods 
which can also be affected by environmental chemical exposures. 
Urinary BPA concentrations during the second trimester of gestation 
were associated with higher serum inhibin B (INHB) levels in peripu-
bertal boys, and with higher TT levels in peripubertal girls (Watkins 
et al., 2017a, 2017b). INHB is produced by Sertoli cells, and its levels 
directly reflect the status of the testis germinative epithelium. Low 
INHB levels have been associated with low testicular function and/or 
with alterations of testicular parameters at histological examination 
(Esposito et al., 2018). Urinary BPA concentrations were cross-sec-
tionally associated with increased serum TT levels and reduced cortisol 
in prepubertal 9–11 year-old boys (Mustieles et al., 2018b). Ad-
ditionally, urinary BPA concentrations were negatively associated with 
serum TT levels among male adolescents and positively associated with 
TT levels in female adolescents in the 2011–2012 National Health and 
Nutrition Examination Survey (NHANES) (Scinicariello and Buser, 
2016). As previously observed in animal studies, there exists a complex 
relationship between BPA and reproductive hormones, which greatly 
depends on the dose, sex and timing at which exposure occurs (dis-
cussed in detail in Mustieles et al. 2018b). 
A case-control study on precocious puberty in girls found that 
higher urinary BPA concentrations correlated with higher urinary 
concentrations of TT, E2 and pregnenolone (PREG) (Lee et al., 2014b), 
while a very small study comparing 28 cases of precocious puberty in 
girls with 28 controls did not find associations between urinary BPA 
and serum E2 or KiSS levels (Özgen et al., 2016). However, KiSS levels 
significantly differed among cases and controls (Özgen et al., 2016). 
KiSS controls the hypothalamic secretion of GnRH and is consequently 
implicated in puberty onset, fertility and pregnancy outcomes 
(Skorupskaite et al., 2014). Given that KiSS appears to be a target of 
BPA exposure in both rodents and non-human primates (Kurian et al., 
2015; Patisaul, 2013), it should be further investigated in HBM studies. 
BPA has been proposed as a risk factor for PCOS, and three case- 
control studies were retrieved from the search. Serum BPA concentra-
tions were associated with increased serum TT and androstenedione 
(AD) levels in adult women (Kandaraki et al., 2011) and with higher 
TT, free testosterone (FT) and dehydroepiandrosterone sulfate (DHEA- 
S) levels among adolescents (Akın et al., 2015). Additionally, another 
case-control study in women with PCOS found a positive association 
between serum BPA concentrations and the free androgen index (FAI) 
(Tarantino et al., 2013). These initial results suggest that BPA-related 
ovarian toxicity may be stronger in PCOS patients. Given the increasing 
prevalence of this condition, further research is warranted. 
BPA may impact female fertility through actions in both the ovary 
and the HP axis, converging in abnormal estrous cyclicity (Viguié et al., 
2018). One of the main molecular targets inside the ovary would be 
aromatase inhibition in antral follicles, through which the production 
of E2 from T would decrease (Viguié et al., 2018). Mok-Lin et al. (2010) 
studied 84 women undergoing fertility treatment finding that higher 
BPA concentrations measured in two urine samples were associated 
with reduced E2 peak levels and reduced oocyte count. These results 
were confirmed in a follow-up study including 174 women by Ehrlich 
et al. (2012). However, the latest follow-up of this study with 256 
women did not replicate previous findings (Mínguez-Alarcón et al., 
2015), which may be influenced by the progressive decline in BPA 
concentrations observed over the years in the U.S. (LaKind et al., 2019).  
Bloom et al. (2011) studied 44 women attending another fertility clinic 
and also found that free serum BPA concentrations were inversely as-
sociated with E2 levels, but this time no association was observed be-
tween BPA concentrations and oocyte count. Finally, a study including 
106 occupationally exposed and 250 non-occupationally exposed 
women reported increased serum prolactin (PRL) and progesterone (P4) 
levels among all females in response to higher urinary BPA con-
centrations. However, when only occupationally exposed participants 
were considered, higher BPA exposure was additionally associated with 
increased serum E2, while reduced follicle stimulating hormone (FSH) 
levels were only observed in non-occupationally exposed women (Miao 
et al., 2015). The results from Miao et al. (2015) suggest that different 
biomarker profiles may be observed in response to different BPA con-
centrations and/or exposure routes (Miao et al., 2015). In other occu-
pational studies, in which inhalation and dermal absorption are thought 
to be the main exposure routes leading to high internal levels of free 
BPA (Hines et al., 2018), different effects would also be expected 
compared to the general population. 
Although the study of reproductive biomarkers in women is parti-
cularly complex due to hormonal variations during different phases of 
the menstrual cycle, the still limited but suggestive evidence calls at-
tention for further HBM studies to correctly address this hypothesis 
strongly substantiated by toxicological data (Peretz et al., 2014; Viguié 
et al., 2018). 
Out of the 10 studies retrieved on BPA and reproductive hormones 
in adult men, all found significant associations with at least one re-
productive hormone; however, not all of them were conducted under 
the same setting and neither reported consistent relationships (Suppl. 
Table 4). In men recruited from the general population, Galloway et al. 
(2010) observed that BPA concentrations measured in one 24-hour 
urine sample were associated with higher serum TT levels, in line with  
Lassen et al. (2014) who reported associations between urinary BPA 
concentrations and increased serum TT, FT, E2, and luteinizing hor-
mone (LH) levels. In contrast, Mendiola et al. (2010) reported that 
urinary BPA was negatively associated with FAI and the FAI/LH ratio, 
and positively associated with serum sex hormone-binding globulin 
(SHBG) levels. In men attending a fertility clinic, urinary BPA con-
centrations were negatively associated with serum INHB levels and the 
E2:TT ratio, and positively associated with FSH and the FSH:INHB ratio 
(Meeker et al., 2010a). Den Hond et al. (2015) observed reduced serum 
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TT levels in response to higher urinary BPA concentrations from males 
seeking fertility care. Vitku et al. (2016) assessed BPA concentrations 
and 11 steroid hormones in the plasma and seminal plasma of male 
attending a fertility center. Plasma BPA was positively correlated with 
estrone (E1), E2, PREG, 17-OH-PREG and DHEA, while negatively as-
sociated with dihydrotestosterone (DHT) levels. In contrast, seminal 
BPA was negatively associated with P4, 17-OH-P4 and DHEA, but si-
milarly correlated with E2 and estriol (E3) (Vitku et al., 2016). Among 
the strengths of Vitku et al. (2016) are the measurement of both BPA 
exposure and hormone biomarkers using a previously validated hy-
phenated mass spectrometry methodology in circulating blood and 
semen. In studies with occupationally and non-occupationally exposed 
men, higher serum BPA concentrations were associated with reduced 
serum AD, FT and FAI, and increased SHBG levels (Zhou et al., 2013), 
as well as with reduced serum AD and increased SHBG levels (Zhuang 
et al., 2015). Additionally, urinary BPA was associated with increased 
levels of PRL, E2 and SHBG, as well as with reduced serum levels of 
FSH, AD and FAI (Liu et al., 2015). 
BPA exposure has also been related to lower sperm counts and/or 
poorer semen quality (Suppl. Table 5). In several cross-sectional stu-
dies, urinary BPA concentrations were associated with poorer semen 
parameters in adults (Knez et al., 2014; Lassen et al., 2014; Li et al., 
2011; Meeker et al., 2010b), while in others were not (Goldstone et al., 
2015; Mendiola et al., 2010). Interestingly, Vitku et al. (2016) found 
that BPA concentrations assessed in seminal plasma, but not in blood 
plasma, were negatively correlated with sperm count, concentration 
and morphology, suggesting that circulating BPA concentrations may 
not have the same biological meaning than exposure measured at this 
localized fluid. Semen is produced by different organs and constitutes a 
non-invasive biological sample that fits very well the exposure-effect 
biomarker paradigm discussed in this work, since it can provide in situ 
exposure and effect data specific to the male reproductive system, and 
at different levels of biological organization: from cell counts and sperm 
morphology/vitality, to seminal hormones, and sperm epigenetic and 
gene expression markers (Bonache et al., 2012), among many other 
molecular markers (Sutovsky and Lovercamp, 2010) and omics ap-
proaches (Huang et al., 2019). 
Among Korean male and female adults participating in a large na-
tional biomonitoring survey, urinary concentrations of E1, E2 and their 
hydroxylated metabolites were higher in the participants with highest 
urinary BPA concentrations compared to the low-exposed group. 
Estrogen metabolism to 4-hydroxy-E1 and 4-hydroxy-E2 was more ac-
tive than that to 2-hydroxy-E1 and 2-hydroxy-E2 among participants in 
the high BPA exposure group, with possible implications for breast 
cancer and other endocrine disorders (Kim et al., 2014). 
BPA has previously been associated with neonatal outcomes in-
cluding lower birth weight and preterm birth in epidemiologic studies 
(Mustieles et al., 2020, 2018c; Pergialiotis et al., 2018), although un-
derlying mechanisms are poorly understood. Ferguson et al. (2015) 
found that maternal urinary BPA concentrations measured at four times 
during pregnancy were associated with higher plasma levels of soluble 
fms-like tyrosine kinase-1 (sFlt-1), and a higher sFlt-1/placental growth 
factor (PlGF) ratio, suggesting a disrupted placental development. 
Among the strengths of Ferguson et al., (2015) are the repeated col-
lection and measurement of BPA in urine and of sFlt-1/PlGF in serum 
up to four times throughout pregnancy using validated methodologies. 
While PlGF is a pro-angiogenic placental protein, which plays an im-
portant role in vascularization, sFlt-1 binds to PlGF making it anti-an-
giogenic. Lower circulating levels of PlGF and higher levels of sFlt-1 
during pregnancy predict pregnancy complications such as pre-
eclampsia and fetal growth restriction (Ferguson et al., 2015). The sFlt- 
1:PlGF ratio is a promising effect biomarker of placental function that 
should be further explored. 
Overall, the results show that serum LH, FSH, E2, TT and SHBG 
levels are the reproductive markers more frequently evaluated in HBM 
studies in both children and adult populations (Table 2). The 
measurement of SHBG levels allows the estimation of FT levels and FAI 
(Table 2). The E2:TT ratio is used as a measure of aromatase activity. 
TT:LH and FSH:INHB ratios are employed as biomarkers of Leydig and 
Sertoli function, respectively (Meeker et al., 2010a). Other useful and 
less studied effect biomarkers are INHB and AMH levels as markers of 
Sertoli function, and INSL3 as a marker of Leydig function (Table 2). 
Additionally, the adrenal androgen DHEA-S and cortisol have been 
studied as biomarkers of adrenarche in prepubertal children, and KiSS 
as biomarker of puberty onset. The sFlt1:PlGF ratio should also be 
further explored as a marker of placental function. Other less studied 
markers include AD, DHT, PRL, PREG and P4 (Table 2). One of the main 
shortcomings observed across studies is the absence of a harmonized 
panel of hormonal markers to assess a specific function in a particular 
age group. Importantly, several hormonal biomarkers should be as-
sessed in combination to adequately characterize a complete biological 
pathway. This approach may counteract the variability associated with 
steroid hormone levels and account for feedback regulations, facil-
itating data interpretation. 
3.1.2.2. Glucocorticoid hormones. Increasing evidence shows that BPA, 
among other environmental chemicals, may disrupt the 
hypothalamic–pituitaryadrenal (HPA) axis altering the stress response 
(Michael Caudle, 2016). However, scarce human data is available 
(Suppl. Table 6). In a longitudinal birth cohort, higher maternal 
urinary BPA concentrations at second trimester of pregnancy were 
associated with a dysregulation of the maternal daytime cortisol pattern 
in saliva, including reduced cortisol at waking and a flatter daytime 
pattern (Giesbrecht et al., 2016). In a consecutive study, the offspring of 
these women was followed-up and cortisol levels were measured in 
infant’s saliva before and after an infant stressor (blood draw) at 
3 months of age (Giesbrecht et al., 2017). The authors found that 
maternal prenatal urinary BPA concentrations were associated with 
increases in baseline cortisol levels among female infants but decreases 
among males (Giesbrecht et al., 2017). In contrast, after the blood draw 
(i.e. the stressor), maternal BPA concentrations were associated with 
increased cortisol compared to baseline levels among males, but 
decreased levels among female infants, suggesting a sex-specific effect 
of BPA on HPA-axis function (Giesbrecht et al., 2017). In peripubertal 
boys from the Spanish INMA-Granada cohort, higher urinary BPA 
concentrations were cross-sectionally associated with reduced serum 
cortisol levels and a higher TT:cortisol ratio, suggesting a potential 
effect at the adrenal gland (Mustieles et al., 2018b). More studies are 
needed to further elucidate the role of BPA exposure on the stress 
response, preferably with a more complete characterization of the HPA 
axis (Table 2). 
3.1.2.3. Thyroid hormones (THs). THs play critical roles in 
differentiation, growth, and metabolism and are required for the 
normal function of all tissues (Yen et al., 2006), most notably for 
normal brain development (Bernal, 2005). While various MoAs 
underlying BPA’s effect on the hypothalamic-pituitary-thyroid (HPT) 
axis are described in experimental studies (Dang et al., 2009; Moriyama 
et al., 2002; Sheng et al., 2012), epidemiologic studies are scarce and 
the majority differ in scope, focus and consequently in the effect 
biomarkers tested (Table 2 and Suppl. Table 7). Overall, associations 
between BPA exposure and circulating THs are difficult to interpret in 
the cases when significant associations are described, calling for 
additional research using more complete datasets pertaining to the 
HPT axis. Nonetheless, while not consistently significant, an inverse 
association between BPA and thyroid-stimulating hormone (TSH) is 
repeatedly observed in adults (Meeker et al., 2010a) in conjunction 
with increased free triiodothyronine (FT3) (Wang et al., 2013) or 
decreased total thyroxine (TT4) (Meeker and Ferguson, 2011) in 
pregnant women (Aung et al., 2017) and in newborns (Brucker-Davis 
et al., 2011; Chevrier et al., 2013; Romano et al., 2015). Additionally, 
free thyroxine (FT4) and serum BPA levels were negatively correlated 
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in men (Sriphrapradang et al., 2013) and positively correlated in 
pregnant women (Aker et al., 2016; Aung et al., 2018). Assessment of 
thyroid autoimmunity provides a more exhaustive characterization of 
thyroid disruption. In the only study focused on thyroid autoimmunity, 
thyroid peroxidase autoantibodies (TPOab) positivity was significantly 
higher across increasing serum BPA quartiles in adults (Chailurkit et al., 
2016). 
Birth cohorts have also reported an inverse relationship between 
maternal BPA exposure and maternal TSH (Aung et al., 2017) and sex- 
specific TSH levels in newborns (Chevrier et al., 2013; Romano et al., 
2015). Since mild or transient variations in THs during development 
affect offspring cognitive outcomes (Bernal, 2005), further investiga-
tion is warranted. 
3.1.2.4. Metabolic biomarkers. BPA is a suspected obesogenic 
compound that promotes fat accumulation in experimental animals 
(Wassenaar et al., 2017), but also a metabolic disruptor able to alter 
glucose homeostasis at very low doses (Alonso-Magdalena et al., 2015), 
and to alter satiety signals (Heindel et al., 2017). Below we summarize 
and discuss the most important biomarkers of whole-body metabolism 
retrieved (Table 2 and Suppl. Table 8). 
Few studies have explored the association between BPA exposure 
during pregnancy and maternal glucose homeostasis. Urinary BPA 
concentrations at second trimester, but not first trimester of pregnancy, 
were positively associated with blood glucose levels 1-hour after a 50-g 
glucose challenge test at 24–28 weeks of gestation (Chiu et al., 2017). 
However, a case-control pilot study and a prospective mother–child 
cohort study that evaluated urinary BPA during the first trimester did 
not find a higher risk of gestational diabetes mellitus (Robledo et al., 
2013; Shapiro et al., 2015). 
The HOMA-IR is a validated biomarker based on fasting glucose and 
insulin levels used to quantify peripheral insulin resistance and pan-
creatic beta-cell function (HOMA-B) (Borai et al., 2011). In children, 
some studies have found higher HOMA-IR values in response to higher 
BPA concentrations, especially among obese subjects (Khalil et al., 
2014; Lee et al., 2013; Menale et al., 2017), while others have not (Eng 
et al., 2013; Watkins et al., 2016). Adipokine levels seem to be early 
metabolic indicators of BPA exposure. Leptin secretion by adipose 
tissue is proportional to fat mass and regulates energy balance. While 
leptin upregulates proinflammatory cytokines related to insulin re-
sistance, adiponectin exerts opposing anti-inflammatory and insulin- 
sensitizing actions (López-Jaramillo et al., 2014). Several studies in 
neonates (Ashley-Martin et al., 2014; Chou et al., 2011), children 
(Menale et al., 2017; Volberg et al., 2013; Watkins et al., 2016) and 
adults (Rönn et al., 2014; Zhao et al., 2012) suggest that both leptin and 
adiponectin (and probably other adipokines) could be sensitive early 
markers of BPA metabolic disruption, especially important in the case 
of infants and children. Although the previous studies varied in study 
design, critical window of development and matrix for BPA exposure 
assessment, they point to a similar direction. Importantly, Menale et al. 
(2017) confirmed their observational findings in adipocytes isolated 
from eight prepubertal children, showing a decrease in adiponectin 
after in vitro BPA dosing. This is in line with described BPA actions in 
the adipose tissue of experimental animals (Wassenaar et al., 2017), as 
well as previously reported associations between BPA exposure and 
obesity in children (Kim et al., 2019; Mustieles et al., 2019) and pos-
sibly in adults (Oppeneer and Robien, 2015; Rancière et al., 2015). 
Therefore, the use of these markers of adipose tissue function should be 
encouraged. On the contrary, serum lipids [triglycerides (TG), total 
cholesterol (TC), high-density lipoprotein cholesterol (HDL-C) and low- 
density lipoprotein cholesterol (LDL-C)] do not seem to be sensitive 
biomarkers of BPA-related metabolic effects in children (Eng et al., 
2013; Khalil et al., 2014; Perng et al., 2017). 
The relationship between adult BPA exposure and biomarkers of 
glucose homeostasis has been relatively well-studied, mostly under a 
cross-sectional design. Higher BPA concentrations have been associated 
with increased glycated hemoglobin (HbA1c) levels in adults from the 
NHANES (Silver et al., 2011) and adult men from the Canadian Mea-
sures Health Survey (CMHS) (Tai and Chen, 2016). In the NHANES, 
urinary BPA was positively associated with greater serum insulin levels 
and insulin resistance (HOMA-IR) (Beydoun et al., 2014), higher risk of 
prediabetes (Sabanayagam et al., 2013), and higher chances of type 2 
diabetes mellitus (T2DM) independently of other risk factors (Shankar 
and Teppala, 2011). Other Asiatic cross-sectional surveys have also 
reported similar results for the risk of T2DM (Aekplakorn et al., 2015; 
Ning et al., 2011), and insulin resistance (Wang et al., 2012). Moreover, 
a prospective study identified a susceptible group of adults for BPA 
effects on glucose homeostasis based on a genetic risk score (Bi et al., 
2016). Fasting circulating glucose and insulin levels, together with 
HOMA (-IR and -B) estimations constitute valid biomarkers of insulin 
resistance, prediabetes and T2DM, which have been consistently asso-
ciated with BPA exposure (Hwang et al., 2018). Future studies should 
evaluate whether BPA substitutes can also interfere with glucose 
homeostasis. 
Similar to studies in children, serum lipid levels in adults do not 
seem to be good metabolic biomarkers for BPA effects (Lang et al., 
2008; Milošević et al., 2017; Savastano et al., 2015). In contrast, several 
associations have been reported for liver enzymes, including clinically 
abnormal serum levels of gamma glutamyl transpeptidase (GGT), lac-
tate dehydrogenase (LD) and alkaline phosphatase (AP) in adults from 
the NHANES (Lang et al., 2008; Melzer et al., 2010), and increased 
serum aspartate aminotransferase (AST), alanine aminotransferase 
(ALT) and GGT levels in elderly (Lee et al., 2014a). More studies are 
needed to elucidate whether BPA exposure could impact liver function 
in adults. 
Low-grade chronic inflammation is closely related to obesity and 
metabolic syndrome (Saltiel and Olefsky, 2017). BPA exposure has been 
associated with higher levels of serum inflammatory markers such as 
interleukin (IL)-6 and tumor necrosis factor alpha (TNF-α) (Savastano 
et al., 2015), high-sensitivity c-reactive protein (hs-CRP) (Choi et al., 
2017), CRP (Lang et al., 2008) and IL-10 (Song et al., 2017). However, 
more experimental and epidemiologic data are needed to better un-
derstand the possible mediating role of inflammation in BPA-related 
metabolic effects. 
The albumin:creatinine ratio (ACR) is considered a biomarker of 
early endothelial dysfunction in both children and adults (Bartz et al., 
2015). In NHANES, childhood urinary BPA concentrations were cross- 
sectionally associated with higher urinary ACR levels (Trasande et al., 
2013). Another cross-sectional analysis among Chinese adults found 
similar associations between urinary BPA and a higher risk of low-grade 
albuminuria (Li et al., 2012). Interestingly, a recent pilot study de-
tecting more BPS than BPA concentrations in children’s urine, found 
that BPS but not BPA concentrations were associated with a higher 
urinary ACR (Kataria et al., 2017). The ACR should be further studied 
as a potential biomarker of BPA-related endothelial dysfunction. 
Beyond its skeletal effects, vitamin D receptors have been found in 
many tissues, including the cardiovascular, immune, and reproductive 
systems (Norman, 2008). In NHANES, higher urinary BPA concentra-
tions were cross-sectionally associated with reduced vitamin D levels in 
women but not in men (Johns et al., 2016). Maternal prenatal urinary 
BPA was also associated with reduced maternal serum vitamin D levels 
and a higher risk of deficiency (Johns et al., 2017). Additionally, among 
patients with chronic obstructive apnea, serum BPA concentrations 
were negatively associated with serum vitamin D levels (Erden et al., 
2014a). Further studies are warranted to understand the possible in-
teraction between bisphenols and altered levels of the so-called “hor-
mone D” (Norman, 2008). 
3.1.2.5. Allergy/Immune biomarkers. Immunoglobulin (Ig)E and specific 
IgE antibodies play an important role in allergic (atopic) processes 
including asthma (Froidure et al., 2016). A prospective study among 
Taiwanese children assessed urinary BPA and serum IgE at 3 and 
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6 years of age (Wang et al., 2016b). Higher BPA concentrations at age 3 
were cross-sectionally associated with increased IgE levels, particularly 
in girls. Similar results were found at age 6. BPA concentrations at age 3 
were prospectively associated with increased IgE levels at age 6. 
Additionally, IgE levels mediated 70% of the total effect of BPA on 
asthma risk (Wang et al., 2016b). In NHANES, urinary BPA was 
positively associated with allergic asthma in adult females, and with 
sensitization to various specific allergens in a dose–response manner 
(Vaidya and Kulkarni, 2012). On the contrary, maternal first-trimester 
urinary BPA concentrations were non-linearly associated with cord 
blood IL-33 and thymic stromal lymphopoietin (TSLP), but not IgE 
levels, in a Canadian mother–child cohort (Ashley-Martin et al., 2015). 
The possible mediating role of both total and specific IgE antibodies in 
BPA-related allergic sensitization should be further explored. 
3.2. Prioritization of effect biomarkers in HBM studies 
A wide range of existing bisphenol-related effect biomarkers were 
identified for most of the human health outcomes screened. Those 
biomarkers with potential application in HBM studies and supported by 
mechanistic knowledge organized under the AOP framework were 
prioritized. First, we discussed the advantages of assessing KiSS and 
gene expression of nuclear receptors in relation to reproductive effects 
based on a previously published BPA-related AOP (Viguié et al., 2018). 
Second, given that biomarkers of brain function were identified as the 
most important knowledge gap, but no previous BPA-related AOP was 
available in this area, we built a network integrating mechanistic in-
formation on BDNF from three fully-developed AOPs, additionally 
identifying the pathways through which BPA could lead to altered 
BDNF function. 
3.2.1. Reproductive effect biomarkers 
Previous studies have observed significant associations between 
bisphenols exposure and altered reproductive hormone levels (Suppl. 
Table 4). However, in many cases the interpretation is hindered by 
diurnal variations in steroid levels, sets of hormones analyzed, analy-
tical techniques used, periods of exposure and feedback loop effects. 
The implementation of other complementary effect biomarkers at dif-
ferent levels of biological organization could therefore help to achieve a 
broader and more accurate picture. A recent evidence-based AOP has 
exhaustively underpinned the endocrine pathways through which fe-
male developmental and/or adult BPA exposure may alter estrous cy-
clicity, thus increasing the risk of adverse fertility and birth outcomes 
(Viguié et al., 2018). 
Fig. 3 synthesizes and depicts the endocrine pathways and tissues 
potentially disrupted by BPA exposure in females, adapted from Viguié 
et al. (2018). Briefly, BPA has been consistently shown to reduce ar-
omatase activity in Granulosa cells, thus preventing the preovulatory 
rise of estrogens at the ovary (Peretz et al., 2014; Viguié et al., 2018). 
Additionally, BPA has been shown to act at a central level, interfering 
with the function of Kisspeptinergic neurons, delaying or suppressing 
the gonadotrophin-dependent peak of LH needed to achieve ovulation 
as shown in both rodents and primates (Kurian et al., 2015; Ruiz-Pino 
et al., 2019; Viguié et al., 2018). Thus, BPA might alter estrous cyclicity 
and ovulation acting locally in the ovary, centrally in the hypotha-
lamus, or both. 
In HBM studies, measuring KiSS protein levels in serum, together 
with traditional hormone markers (LH, FSH, E2 and TT) may allow a 
better characterization of potential BPA actions on the HP axis (Fig. 3). 
Serum KiSS levels could also help to identify the menstrual period in 
which the sample was taken (Zhai et al., 2017). Similar to other effect 
biomarkers, particular attention must be given to the storage of samples 
under the best conditions in order to avoid a potential degradation of 
this protein over time (Gejl et al., 2019). In addition, evaluating KiSS at 
other biological levels with higher stability over time, such as for ex-
ample DNA methylation of KISS1 in peripheral blood mononuclear cells 
(PBMCs), could help to counteract the variability related to circulating 
levels. KiSS plays a crucial role during pregnancy and puberty onset, 
but also during adulthood regulating the ovulatory mechanism (Cortés 
et al., 2015). Emerging data is also showing a cross-talk between adi-
pose tissue and kisspeptinergic neurons mediated through the adipo-
kine leptin (Cortés et al., 2015). Overall, KiSS represents an under-
studied but promising effect biomarker of both reproductive and 
metabolic health. 
Apart from fertility clinic settings in which human oocyte retrieval 
and follicular fluid sampling is possible (Machtinger et al., 2013), as-
sessing whether BPA may decrease aromatase activity in the ovary is 
not possible in HBM studies using non-invasive matrices. Notwith-
standing, the gene expression and/or DNA methylation of estrogenic 
receptors [estrogen receptor (ER)α, ERβ, estrogen-related receptor 
(ERR)α, etc.] and perhaps other molecular targets in blood cell popu-
lations could help to evaluate the biological plausibility of BPA asso-
ciations as previously shown (Melzer et al., 2011), especially when 
complemented with the abovementioned set of reproductive biochem-
ical biomarkers. Indeed, aromatase gene expression in peripheral blood 
leukocytes from adult women was significantly higher during the fol-
licular phase compared to the luteal phase of the menstrual cycle, and 
its expression was correlated with circulating E1 and E2 serum levels 
(Vottero et al., 2006). Thus, aromatase expression in women’s blood 
could represent an interesting surrogate of local aromatase expression 
in the ovary. Future studies should investigate whether the expression 
and epigenetic status of molecular markers in PBMCs is predictive of 
adverse health effects in human populations. 
3.2.2. Neurodevelopmental/neurological effect biomarkers 
The neurotrophin BDNF is a promising effect biomarker that could 
fill an important knowledge gap regarding neurodevelopmental out-
comes associated with bisphenols exposure. However, organized data 
on potential mechanistic pathways that could lead to altered BDNF 
levels (and other targets) are needed to support its implementation in 
HBM studies, as well as identify potential novel molecular markers of 
brain function. Fig. 4 shows the result of integrating three fully-devel-
oped AOPs sharing the key event “reduced BDNF release” leading to the 
same AO: impaired learning and memory. Numbers inside boxes cor-
respond to scientific articles referenced below. 
In AOP 54, BPA may decrease TH levels through mechanisms in-
volving the sodium/iodide symporter (NIS) and thyroperoxidase (TPO) 
as illustrated by reduced iodide uptake through non-competitive in-
hibition of NIS (Wu et al., 2016) [number 11 in Fig. 4] and decreased 
mRNA levels of Nis and tpo (Silva et al., 2018) [12] in rat thyroid fol-
licular cell lines, and decreased TPO activity and NIS-mediated thyroid 
radioiodide uptake in BPA-exposed rats (Silva et al., 2018). Never-
theless, Silva et al. (2018) reported increased serum T4 levels, which 
contradicts expected effects in this AOP and other studies showing 
decreased T4 levels in pregnant ewes and their offspring (Viguié et al., 
2013) [13] and aged mice with learning and memory deficits following 
pubertal exposure (Jiang et al., 2016) [14]. 
AOPs 12 and 13 describe causal events initiated by inhibition of 
glutamate N-methyl-D-aspartate receptors (NMDARs). AOP 13 focuses 
on KEs occurring during brain development and AOP 12 adds down-
stream events during aging. Reduced hippocampal mRNA and/or pro-
tein expressions of NMDAR subunits along with negative effects in 
different forms of learning and memory were reported in male offspring 
mice (Xu et al., 2010) [1] and rats (Wang et al., 2014) [2] prenatally 
exposed to BPA; in mice of both sexes following prenatal and postnatal 
exposure (Tian et al., 2010) [5]; and in mice exposed postnatally 
(Jardim et al., 2017) [4]. 
A single neonatal dose of BPA in mice may reduce hippocampal 
levels of Calcium/calmodulin-dependent kinase II (CaMKII), a protein 
activated by calcium influx and crucial for learning and memory 
(Viberg and Lee, 2012) [15]. In addition to impaired learning and 
memory, prenatal exposure to BPA decreased hippocampal levels of 
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phosphorylated cAMP response-binding element (CREB), known to be 
triggered by Ca2 + influx (Tao et al., 1998), and its target BDNF in 
male rats (Wang et al., 2016a) [17], and decreased mRNA levels of 
NMDAR2B and BDNF in male mice (Kundakovic et al., 2015) [16]. 
Importantly for HBM purposes, BDNF CpG methylation profiles in mice 
blood reflected methylation profiles and transcription levels in the 
hippocampus, suggesting that blood BDNF DNA methylation may be a 
valid surrogate marker of human brain BDNF expression levels 
(Kundakovic et al., 2015) [16]. 
As expected from BDNF’s critical role in dendritic arborization and 
synaptic plasticity (Kowiański et al., 2018), decreased dendritic spine 
density in region CA1 of the hippocampus (critical for memory for-
mation) was reported in rats following postnatal exposure to BPA 
(Bowman et al., 2014) [8] and in neonates of non-human primates 
exposed in utero (Elsworth et al., 2013) [6]. Prenatal exposure also 
reduced the length and number of dendritic branches of postnatal mice, 
with long-term effects consisting of reduced spine densities in hippo-
campal CA1 of aged mice (Kimura et al., 2016) [9]. Inhibition of 
NMDAR1, decreased synaptic proteins (e.g., PSD-95, synapsin I, sy-
naptophysin or spinophilin) and altered synaptic structure were ob-
served in the hippocampus of male mice exposed perinatally (Xu et al., 
2013) [7], and rats exposed prenatally (Wang et al., 2014) [2]. Fur-
thermore, perinatal exposure reduced expression of synaptophysin and 
the excitatory to inhibitory synaptic protein ratio in the hippocampus 
and cortex of male mice (Kumar and Thakur, 2017) [3]. 
In turn, neuronal network function as evaluated by electro-
physiological techniques may be compromised. BPA decreased the in-
duction of hippocampal long-term potentiation (LTP) in juvenile rats 
together with reduced NMDAR-mediated postsynaptic current in hip-
pocampal slices. Moreover, consistent with inhibited NMDARs, de-
creased spine density and pre-synaptic glutamate release, spatial 
memory was impaired (Hu et al., 2017) [10]. 
In addition to fewer neurons in various regions of the hippocampus, 
decreased hippocampal LTP induction and impaired learning and 
memory, Zhou et al. (2017) [18] demonstrated a dose-dependent DNA 
damage in adolescent male mice brains after chronic exposure. BPA 
treatment also reduced the viability of hippocampus-derived neural 
stem cells and induced apoptosis and neurodegeneration in the 
hippocampus of rats exposed perinatally (Tiwari et al., 2015) [19] and 
postnatally with deficits in memory and learning (Agarwal et al., 2015) 
[20]. The contribution of neuroinflammation to the neurodegenerative 
effects of BPA is substantiated by increased numbers of microglia in the 
dentate gyrus of both postnatal rats and adult female voles exposed 
during early development (Rebuli et al., 2016) [21]. Furthermore, 
maternal BPA increased microglial and astrocyte activation and ele-
vated TNF-α and IL-6 levels in the prefrontal cortex of female offspring 
mice (Luo et al., 2014) [22]. 
Several potential biomarkers of effects related to the aforemen-
tioned KEs may be relevant for HBM studies. For instance, in seven year 
old girls, buccal DNA methylation levels of the gene encoding 
NMDAR2B were positively associated with prenatal urinary BPA con-
centrations (Alavian-Ghavanini et al., 2018). Specific protein 4 (SP4), a 
key regulator of NMDAR signaling (Priya et al., 2013), has been pro-
posed as a biomarker of early stage psychosis (Fusté et al., 2013; 
Pinacho et al., 2015), being a sensitive target of BPA exposure in vivo 
(Lam et al., 2011). Additionally, glial cell-derived neurotrophic factor 
(GDNF) plays an important role in various neuropsychiatric disorders 
(Ibáñez and Andressoo, 2017) and may be modulated by BPA along 
with alterations of dopamine and serotonin systems in rats (Castro 
et al., 2015). Finally, synapsin I, an important protein for neuro-
transmitter release and synaptic function exhibited similar expression 
patterns in both PBMCs and the hippocampus of rats and may serve as 
an early biomarker of cognitive function (Cifre et al., 2018). 
Fig. 4 integrates the pathways presented in the three selected AOPs; 
however, other mechanisms not covered in those AOPs may also be 
important. For example, NMDAR inhibition plays a fundamental role in 
this network as a MIE, but also as a KE when regulated via nuclear ERs 
in the hippocampus (El-Bakri et al., 2004). Indeed, ERs colocalize to 
cells that express BDNF (Sohrabji and Lewis, 2006), and previous ex-
perimental evidence suggests that BPA actions in the hippocampus may 
be mediated by altered estrogenic signaling (Chen et al., 2017; Leranth 
et al., 2008). Thus, BPA could lead to altered BDNF function through at 
least two MoAs: disruption of thyroid and estrogenic pathways. At an 
HBM level, evaluating a combined set of effect biomarkers implicated in 
this AOP network (mainly THs and BDNF) could better characterize the 
neurological effects of bisphenols. Moreover, these targets should be 
Fig. 3. Hypothesized sequential cascade of BPA events leading to development of altered estrous cycle, adapted from AOP data constructed by Viguié et al. (2018). 
BPA (bisphenol A); E2 (17β-estradiol); GnRH (gonadotropin-releasing hormone); LH (luteinizing hormone); FSH (follicle stimulating hormone). 
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assessed at different levels of biological organization (protein levels, 
gene expression, DNA methylation, etc.) to achieve the most complete 
picture possible. 
A limitation of this AOP network is that the three available AOPs 
focused on learning and memory, while no AOPs discussing the role of 
BDNF on behavioral and psychiatric diseases were retrieved from the 
AOP-Wiki. It’s known that BDNF also plays a role in the development of 
anxiety, depression and mood disorders (Martinowich et al., 2007), and 
previous reviews of the epidemiologic evidence found that prenatal 
BPA exposure is associated with behavioral problems in children 
(Ejaredar et al., 2017; Mustieles et al., 2015; Rodríguez-Carrillo et al., 
2019). Therefore, the role of neurotrophins as potential mediators of 
bisphenol-related actions on behavioral and emotional problems should 
be also considered in future epidemiologic studies. 
4. Conclusions and future perspectives 
This comprehensive literature search has allowed us to create the 
first inventory of existing effect biomarkers for bisphenols, but also to 
propose potential novel effect biomarkers that may be implemented in 
HBM studies. The assessment of mechanistically-based effect bio-
markers will help to improve the inference of causal relationships be-
tween bisphenols exposure and adverse health outcomes in future HBM 
and epidemiologic studies. Moreover, parallel efforts for other chemical 
families are ongoing under the HBM4EU initiative (Baken et al., 2019), 
which will result in a structured body of work that will enable a more 
systematic approach for the selection of effect biomarkers in the context 
of exposure to low-dose complex chemical mixtures. This work will also 
help to prioritize the selection of effect biomarkers for BPA substitutes, 
facilitating the evaluation of potential adverse effects in a timely 
manner, without the need to wait for decades until the onset of an overt 
developmental or chronic disease state. 
As a technical limitation, harmonization of measurement meth-
odologies for effect biomarkers in HBM studies is needed, including the 
performance of interlaboratory comparisons and quality controls, to 
avoid variability and misclassification errors, thus improving compar-
ison and replicability among studies. The development of analytical 
methodologies relying on hyphenated mass spectrometry should be 
encouraged to progressively substitute ELISA and other immunoassays 
commonly employed. In relation to BPA exposure assessment, many 
-although not all- of the studies reviewed in this work measured total 
BPA (free and phase II conjugates) in urine samples using previously 
validated hyphenated mass spectrometry methodologies following 
quality assurance and control (QA/QC) measures. In this regard, the 
HBM4EU initiative has fostered an extensive network of European la-
boratories that share QA/QC procedures and undergo interlaboratory 
comparisons to warrant the highest standards for the biomonitoring of 
exposure to priority compounds. At an epidemiological level, pro-
spective designs with repeated measurements for both exposure and 
effect biomarkers need to progressively replace cross-sectional studies 
with only punctual assessments. In addition, future studies should in-
clude the implementation of effect biomarkers as potential mediators in 
the exposure-disease continuum, as a complementary tool to better 
evaluate exposure-health associations. 
Because environmental contaminants such as bisphenols have 
complex MoA, implementation of effect biomarkers at different levels of 
biological organization (e.g., DNA, RNA, proteins or metabolites) seems 
necessary. This point is reinforced considering that, depending on the 
dose, the target tissue or the window of exposure, the MIE and down-
stream events may be different. In this review, we proposed to follow 
the AOP framework for prioritizing the right set of effect biomarkers to 
be studied. However, there is a limited number of fully developed 
AOPs. Consequently, efforts are needed to develop more AOPs for many 
endpoints and xenobiotics, which is another objective of the HBM4EU 
initiative. The biomarker paradigm and AOP framework (Figs. 1 and 2) 
have been followed in this review to provide a practical and visual 
conceptualization to advance the field of effect biomarkers. Although 
this structured framework presents many strengths, we acknowledge 
inherent limitations such as the potential existence of non-monotonic 
dose–response relationships, the inability to assess dose at target or-
gans, and the difficulty of assessing combined effects in the context of 
complex chemical mixtures. 
In future HBM studies, the combined use of multi-omics technolo-
gies to perform global characterization of genes (genomics), genome 
Fig. 4. Network integrating MIEs and KEs from AOPs 12, 13 and 54 leading to a reduced release of BDNF (Boxes), and identification of the steps that can be triggered 
or promoted by BPA based on available mechanistic data (numbers inside boxes indicate scientific articles referenced in the manuscript). 
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wide epigenetics, mRNA (transcriptomics), proteins (proteomics) and 
metabolites (metabolomics) in a specific biological sample seems a very 
good option to overcome the limitation of looking at the wrong biolo-
gical level of organization, or the wrong biological targets. Although 
these technologies are still expensive and require expertise to analyze 
and interpret the tremendous amount of data generated, systems 
biology is expanding at a fast rate and the corresponding computational 
tools are expected to be developed. Moreover, multi-omics should be 
able to explain complex biological phenomena not only for a class of 
xenobiotics but for multiple stressors. Hence, untargeted analyses 
should be encouraged, preferably coupled to targeted analyses, in order 
to uncover the right biological pathways disrupted by xenobiotics, and 
their corresponding sets of effect markers. 
There is an increasing need to rapidly evaluate the safety of ex-
posure to emerging chemicals in human populations. However, many 
diseases are only triggered after years of chronic exposure to multiple 
xenobiotics. Therefore, 21st century environmental policymakers may 
have to consider whether regulation of chemical contaminants should 
be proactive and informed by changes in molecular profiles predictive 
of adverse effects, rather than a sine qua non reliance on firm health 
endpoints that may take decades to investigate. 
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